| 1 |
Edward R. Damiano |
Beta Bionics |
15 |
| 2 |
Barry Weitzner |
Boston Scientific Scimed |
12 |
| 3 |
Alexandre Megretski |
Nanosemi |
11 |
| #4 |
Bo Zhou |
Skyworks Solutions |
10 |
| #5 |
Wei Zhang |
IBM |
9 |
| #6 |
Thomas K. Skripps |
Allen Medical Systems |
8 |
| #6 |
Anil Jeswani |
Ledvance Gmbh |
8 |
| #8 |
Tao Hong |
BOE |
7 |
| #9 |
Rohit Prasad |
Amazon |
6 |
| #9 |
Alexandre Joseph Buckmelter |
Forma Therapeutics |
6 |
| #9 |
Minghua Wang |
Forma Therapeutics |
6 |
| #9 |
Julian Horn |
IBM |
6 |
| #13 |
Joris Wils |
Emc Ip Holding Company |
5 |
| #13 |
Hailing Wang |
Skyworks Solutions |
5 |
| #13 |
Sampath Dechu |
IBM |
5 |
| #13 |
Bradford C. Sippy |
Lennham Pharmaceuticals |
5 |
| #13 |
Peter Beale |
Emc Ip Holding Company |
5 |
| #13 |
Paul Dormitzer |
Intel |
5 |
| #13 |
Gary Kappel |
Boston Scientific Scimed |
5 |
| #13 |
Simon N. Peffers |
Intel |
5 |
| #21 |
Yuhong Huang |
Rockwell Automation |
4 |
| #21 |
Stuart D. Sandberg |
Commscope Technologies |
4 |
| #21 |
Guo-Qing Tang |
Ra Pharmaceuticals |
4 |
| #21 |
Kirill K. Pankratov |
Symbotic |
4 |
| #21 |
Teck Ping Sim |
E Ink Holdings |
4 |
| #21 |
Mark Ledeboer |
Vertex Pharmaceuticals Incorporated |
4 |
| #21 |
Xinfa Ma |
Arris Enterprises |
4 |
| #21 |
William S. Yerazunis |
Mitsubishi Electric |
4 |
| #21 |
Jaime M. Stockton |
IBM |
4 |
| #21 |
Nihar Nanda |
Emc Ip Holding Company |
4 |
| #21 |
Rogelio Vazquez-Rivera |
IBM |
4 |
| #21 |
Xuebing Zhang |
Beijing Boe Optoelectronics Technology Co. |
4 |
| #21 |
Neeraj Asthana |
IBM |
4 |
| #21 |
Xuan Kong |
Neurometrix |
4 |
| #21 |
Daniel E. Zeck |
Broadcom |
4 |
| #21 |
Joseph A. Gardecki |
The General Hospital |
4 |
| #21 |
Kyle B. Wheeler |
Micron |
4 |
| #21 |
Scott E. Brechbiel |
Boston Scientific Scimed |
4 |
| #21 |
Robert John Sasena |
Keurig Green Mountain |
4 |
| #40 |
Kevin Wilson |
Hologic |
3 |
| #40 |
Eun Seok Gil |
3-D Matrix |
3 |
| #40 |
Jeffrey C. Marrion |
Allen Medical Systems |
3 |
| #40 |
Jianxiu Hao |
Verizon |
3 |
| #40 |
Shuyu Lee |
Emc Ip Holding Company |
3 |
| #40 |
Shailaja S. Golikeri |
IBM |
3 |
| #40 |
Lawrence L. Kuo |
W.R. Grace & Co.-Conn. |
3 |
| #40 |
Qin-Fan Zhu |
Broadcom |
3 |
| #40 |
Nagendra Anantharamaiah |
Hollingsworth & Vose |
3 |
| #40 |
Antonio Gualberto |
Kura Oncology |
3 |
| #40 |
Alan J. Bitonti |
Syntonix Pharmaceuticals |
3 |